Smith & Nephew SNATS Gross Margin 2010-2024 | SNN

Smith & Nephew SNATS gross margin for the quarter ending June 30, 2024 was 74.83%.

  • Smith & Nephew SNATS average gross margin for 2013 was 74.31%, a 0.53% increase from 2012.
  • Smith & Nephew SNATS average gross margin for 2012 was 73.92%, a 0.54% increase from 2011.
  • Smith & Nephew SNATS average gross margin for 2011 was 73.52%, a 0.05% increase from 2010.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.

Smith & Nephew SNATS Gross Margin 2010-2024 | SNN

  • Smith & Nephew SNATS average gross margin for 2013 was 74.31%, a 0.53% increase from 2012.
  • Smith & Nephew SNATS average gross margin for 2012 was 73.92%, a 0.54% increase from 2011.
  • Smith & Nephew SNATS average gross margin for 2011 was 73.52%, a 0.05% increase from 2010.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$199.9B
Stryker (SYK)$137.7B
Boston Scientific (BSX)$121.6B
Medtronic (MDT)$113B
EssilorLuxottica (ESLOY)$104.4B
Haleon (HLN)$48.1B
Lonza Group Ag (LZAGY)$45.4B
ResMed (RMD)$35B
Koninklijke Philips (PHG)$29B
Terumo (TRUMY)$27.9B
Zimmer Biomet Holdings (ZBH)$21.6B
Baxter (BAX)$20.1B
Insulet (PODD)$16.6B
Bio-Rad Laboratories (BIO)$9.5B
Demant (WILYY)$9.2B
BellRing Brands (BRBR)$7.7B
Lantheus Holdings (LNTH)$7.5B
ICU Medical (ICUI)$4.3B
TG Therapeutics (TGTX)$3.9B
Haemonetics (HAE)$3.9B
Perrigo (PRGO)$3.8B
GN Store Nord (GNNDY)$3.8B
Neogen (NEOG)$3.7B
Prestige Consumer Healthcare (PBH)$3.6B
Envista Holdings (NVST)$3.3B
QuidelOrtho (QDEL)$3.1B
Agios Pharmaceuticals (AGIO)$2.6B
Maravai LifeSciences Holdings (MRVI)$2.3B
Green Thumb Industries (GTBIF)$2.2B
LeMaitre Vascular (LMAT)$2B